SGSivaporn GatechompolMDVideoHIVRSVAsia-Pacific HIV Clinical Forum 2022International and Asian Country Guidelines - Similarities and Differences | Sivaporn Gatechompol, MDView Video
V(TViet (Mason) TrinhBScSlidesetHIVAsia-Pacific HIV Prevention Meeting 2022Con Standpoint of the Debate - Viet (Mason) Trinh, B.S.View Slideset
V(TViet (Mason) TrinhBScVideoHIVAsia-Pacific HIV Prevention Meeting 2022Con Standpoint of the Debate - Viet (Mason) Trinh, B.S.View Video
SWKStephane Wen-Wei KuMDVideoHIVAsia-Pacific HIV Prevention Meeting 2022Con Standpoint of the Debate - Stephane Wen-Wei Ku, MDView Video
ULUdom LikhitwonnawutVideoHIVAsia-Pacific HIV Prevention Meeting 2022Pro Standpoint of the Debate - Udom LikhitwonnawutView Video
JBJakkrapatara BoonruangMDVideoHIVAsia-Pacific HIV Prevention Meeting 2022Pro Standpoint of the Debate | Jakkrapatara Boonruang, MDView Video
GEGGlenda E. GrayMBBCH, FCPaeds (SA), DScVideoHIVAsia-Pacific HIV Prevention Meeting 2022Update on HIV Vaccine and Monoclonal Antibody | Glenda E. Gray, MBBCH, FCPaeds (SA), DScView Video
RSRobin SchaeferBA, MPH, PhDVideoHIVAsia-Pacific HIV Prevention Meeting 2022Long-Acting PrEP in Low- And Middle-Income Countries - Robin Schaefer, BA, MPH, PhDView Video
JFJulie FoxMD, MBChB, BSc, MRCPVideoHIVAsia-Pacific HIV Prevention Meeting 2022PEP in the Era of PrEP - Julie Fox, MBChB. BSc. MRCP. MDView Video
SlidesetHIVAsia-Pacific HIV Prevention Meeting 2022CON Perspective - Debate: When Available, Long-Acting Cabotegravir Should be the First Option for PrEP in Public Health Setting - Viet (Mason) TrinhView Slideset
GEGGlenda E. GrayMBBCH, FCPaeds (SA), DScSlidesetHIVAsia-Pacific HIV Prevention Meeting 2022Update on HIV Vaccine and Monoclonal AntibodyView Slideset
RSRobin SchaeferBA, MPH, PhDSlidesetHIVAsia-Pacific HIV Prevention Meeting 2022Long-Acting PrEP in Low- And Middle-Income CountriesView Slideset
